On July 18, according to reports, OpenEvidence, a medical artificial intelligence startup known as the “Doctor's version of ChatGPT,” is preparing a new round of financing plans. According to reports, due to its strong performance in clinical decision support and medical data analysis, external venture capital institutions are issuing potential valuations of up to 20 billion US dollars and actively seeking shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.